Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(5 sites)

China

Anhui Provincial Cancer Hospital, Hefei, Anhui

Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei

Hunan Cancer Hospital, Changsha, Hunan

Zhejiang Cancer Hospital, Hangzhou, Zhejiang